Literature DB >> 216260

The molecular mode of action of Clostridium perfringens enterotoxin.

J L McDonel.   

Abstract

While certain strains of Clostridium perfringens have been associated with food poisoning outbreaks for the past 30 years, it has been only during the past 10 years that progress has been made in describing the disease process. And only within the past 5 years has meaningful progress been made in understanding the mechanism by which the disease is caused. Early observations, that the protein enterotoxin can cause erythema, increase capillary permeability, and exhibit parasympathomimetic properties, have been greatly added to in more recent studies. It is now believed tht the enterotoxin can alter intestinal transport of fluid, ions, and glucose, cause tissue damage in the gut and inhibit metabolic processes in intestinal tissue. Furthermore, the enterotoxin is thought to act very quickly (in a matter of minutes, compared to hours for other known enteropathogenic factors) and to affect basic function (macromolecular synthesis) and structure (membrane damage to microvillus brush borders) of individual cells. These findings have opened up many new questions that hopefully, when answered, will further the understanding of how this enterotoxin acts, as well as other enterotoxins being studied today.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 216260     DOI: 10.1093/ajcn/32.1.210

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  10 in total

1.  Ribotyping for strain characterization of Clostridium perfringens isolates from food poisoning cases and outbreaks.

Authors:  B Schalch; J Björkroth; H Eisgruber; H Korkeala; A Stolle
Journal:  Appl Environ Microbiol       Date:  1997-10       Impact factor: 4.792

Review 2.  Clostridial enteric diseases of domestic animals.

Authors:  J G Songer
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Morphological alterations and changes in cellular cations induced by Clostridium perfringens type A enterotoxin in tissue culture cells.

Authors:  N Sugimoto; K Ozutsumi; M Matsuda
Journal:  Eur J Epidemiol       Date:  1985-12       Impact factor: 8.082

4.  Highly sensitive assay for Clostridium perfringens enterotoxin that uses inhibition of plating efficiency of Vero cells grown in culture.

Authors:  J L McDonel; B A McClane
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

5.  Clinical and antibody responses to Clostridium perfringens type A enterotoxin in experimental sheep and calves.

Authors:  L Niilo; H J Cho
Journal:  Can J Comp Med       Date:  1985-04

6.  Molecular typing of Clostridium perfringens from a food-borne disease outbreak in a nursing home: ribotyping versus pulsed-field gel electrophoresis.

Authors:  Barbara Schalch; Lutz Bader; Hans-Peter Schau; Rolf Bergmann; Andrea Rometsch; Gertraud Maydl; Silvia Kessler
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

7.  Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?

Authors:  P V Kirjavainen; T Arvola; S J Salminen; E Isolauri
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

8.  Nonradioactive colony hybridization assay for detection and enumeration of enterotoxigenic Clostridium perfringens in raw beef.

Authors:  L A Baez; V K Juneja
Journal:  Appl Environ Microbiol       Date:  1995-02       Impact factor: 4.792

9.  Stimulation of Clostridium perfringens enterotoxin formation by caffeine and theobromine.

Authors:  R G Labbe; L L Nolan
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

10.  Clostridium Perfringens Toxins Involved in Mammalian Veterinary Diseases.

Authors:  F A Uzal; J E Vidal; B A McClane; A A Gurjar
Journal:  Open Toxinology J       Date:  2010
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.